Consolidated Statements of Shareholders' Deficit - USD ($)	Common stock outstanding	Additional paid-in capital	Accumulated deficit	Total
Balance at Dec. 31, 2019	$ 128,997	$ 87,712,695	$ (103,862,127)	$ (16,020,435)
Balance (in Shares) at Dec. 31, 2019	128,997,423
Reverse split restatement adjustment	$ (126,416)	126,416
Reverse split restatement adjustment (in Shares)	(126,415,551)
Restated balance December 31, 2019	$ 2,581	87,839,111	(103,862,127)	(16,020,435)
Restated balance December 31, 2019 (in Shares)	2,581,872
Shares issued upon exercise of options	$ 55	63,195		63,250
Shares issued upon exercise of options (in Shares)	55,000
Shares issued upon exercise of warrants	$ 38	43,270		43,308
Shares issued upon exercise of warrants (in Shares)	37,658
Loss on modification of options and warrants		115,722		115,722
Net loss			(488,275)	(488,275)
Balance at Dec. 31, 2020	$ 2,674	88,061,298	(104,350,402)	(16,286,430)
Balance (in Shares) at Dec. 31, 2020	2,674,530
Net loss			(1,127,454)	(1,127,454)
Balance at Dec. 31, 2021	$ 2,674	$ 88,061,298	$ (105,477,856)	$ (17,413,884)
Balance (in Shares) at Dec. 31, 2021	2,674,530